The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience-Reference-Cited by-同舟云学术

The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

Published:2020-05-28 Issue:2 Volume:183 Page:373-374
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Gisondi P.¹^ORCID,Facheris P.²³,Dapavo P.⁴,Piaserico S.⁵,Conti A.⁶^ORCID,Naldi L.⁷⁸,Cazzaniga S.⁸⁹^ORCID,Malagoli P.¹⁰,Costanzo A.²

Affiliation:

1. Department of Medicine Section of Dermatology and Venereology University of Verona Italy

2. Dermatology Unit Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

3. Humanitas Clinical and Research Center IRCCS Rozzano Italy

4. Department of Biomedical Science and Human Oncology Second Dermatologic Clinic University of Turin Turin Italy

5. Section of Dermatology Department of Medicine University of Padua Padova Italy

6. Department of Surgical Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Dermatology Unit University of Modena and Reggio Emilia Modena Italy

7. Department of Dermatology San Bortolo Hospital Vicenza Italy

8. Centro Studi GISED Bergamo Italy

9. Department of Dermatology Inselspital University Hospital of Bern Bern Switzerland

10. Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19158

Reference6 articles.

1. Time to use the p‐word? Coronavirus enter dangerous new phase;Callaway E;Nature,2020

2. European Centre for Disease Prevention and Control.Situation update for the EU/EEA and the UK. Available at:https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea(last accessed 2 April 2020).

3. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

4. Should biologics for psoriasis be interrupted in the era of COVID-19?

5. American Academy of Dermatology.Guidance on the use of biologic agents during COVID‐19 outbreak. Available at:https://www.aad.org/member/practice/managing/coronavirus(last accessed 2 April 2020).

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination Rates in Patients with Chronic Inflammatory Skin Diseases and Immunomodulatory Systemic Therapies—Vaccinations against SARS-CoV-2, Influenza Virus or Varicella Zoster Virus;Life;2024-09-12

2. Features of psoriasis treatment with infection COVID-19;Vestnik dermatologii i venerologii;2024-07-10

3. Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest;Journal of Clinical Medicine;2024-06-26

4. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries;Psoriasis: Targets and Therapy;2024-05

5. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities;Expert Review of Clinical Pharmacology;2024-04-02